CGHTN - SODIUM IODIDE I 131 THERAPEUTIC CAPSULES

  • MSDS: CGHTN
  • Manufacturer: MALLINCKRODT MEDICAL INC
  • Product Name: SODIUM IODIDE I 131 THERAPEUTIC CAPSULES
  • National Stock Number: 6505-00F054813
Product Identification

Product ID:SODIUM IODIDE I 131 THERAPEUTIC CAPSULES
MSDS Date:01/01/1997
FSC:6505
NIIN:00F054813
MSDS Number: CGHTN

Responsible Party
MALLINCKRODT MEDICAL INC
2703 WAGNER PLACE
MARYLAND HEIGHTS, MO 63043-3421
US

Emergency Phone: 314-770-7800

Info Phone: 314-770-7800/314-895-2000

Cage: FO650

Contractor
MALLINCKRODT MEDICAL INC
MARYLAND HEIGHTS, MO 63043-3421 US

Telephone: 314-770-7800/314-895-2000

Cage: FO650

Ingredients

SODIUM IODIDE I 131 *97-4*

CAS: 7790-26-3

Fraction By Weight: <0.001%


SODIUM PHOSPHATE, DIBASIC, ANHYDROUS, DISODIUM PHOSPHATE

CAS: 7558-79-4

RTECS: WC4500000

Fraction By Weight: 100%

EPA Report Quantity: 5000 LBS

DOT Report Quantity: 5000 LBS

Hazards

Routes of Entry: Inhalation:NO Skin:NO Ingestion:NO
Reports of Carcinogenicity:NTP:NO IARC:NO OSHA:NO
Health Hazards Acute and Chronic:INGESTION: MAY CAUSE ASYMPTOMATIC
PHYSIOLOGICAL UPTAKE BY THYROID GLAND/OTHER TISSUES. EYES: MAY
CAUSE MECHANICAL IRRITATION.
Explanation of Carcinogenicity:NONE
Effects of Overexposure:IRRITATION.

First Aid

First Aid:INGESTION: A THYROID BLOCKING AGENT MAY BE WARRANTED & GIVEN
UNDER THE DIRECTION OF A PHYSICIAN. SKIN: WASH THOROUGHLY W/SOAP &
WATER. ALWAYS BLOT DRY. DON'T ABRADE. EYES: WASH W/WATER FOR 15
MINS. OB TAIN MEDICAL ATTENTION IN ALL CASES.

Fire Fighting

Extinguishing Media:USE ANY MEANS SUITABLE FOR EXTINGUISHING
SURROUNDING FIRE.
Fire Fighting Procedures:WEAR FULL PROTECTIVE CLOTHING & NIOSH APPROVED
SCBA W/FULL FACEPIECE OPERATED IN THE PRESSURE DEMAND/OTHER
POSITIVE PRESSURE MODE.
Unusual Fire/Explosion Hazard:NON-FLAMMABLE.

Accidental Release

Spill Release Procedures:ALL CLEANUP OPERATIONS SHOULD BE PERFORMED
ACCORDING TO THE STANDARD OPERATION PROCEDURES.

Handling

Handling and Storage Precautions:STORE AT 59F-86F. HANDLING TIME SHOULD
BE KEPT TO A MINIMUM & APPROPRIATE SHIELDING SHOULD BE USED.
Other Precautions:USE DEVICES SUCH AS SYRINGE SHIELDS & TONGS FOR
HANDLING. AVOID CONTACT W/THE RADIOACTIVE CONTENTS WHICH WOULD
CAUSE UNNECESSARY EXPOSURE TO RADIATION. THE VIAL CONTAINING THE
DRUG SHOULD BE KEPT W/IN IT'S CONTAINER/HEAVIER SHIELDING.

Exposure Controls

Respiratory Protection:NOT EXPECTED TO REQUIRE PERSONAL RESPIRATOR.
Ventilation:NOT EXPECTED TO REQUIRE ANY VENTILATION.
Protective Gloves:DISPOSABLE PLASTIC/LATEX/RUBBER
Eye Protection:SAFETY GLASSES
Other Protective Equipment:LAB COAT.
Work Hygienic Practices:NO SMOKING, EATING/DRINKING SHOULD BE ALLOWED
IN ANY AREA WHERE RADIOACTIVE MATERIALS ARE HANDLED/STORED.
Supplemental Safety and Health

Chemical Properties

Solubility in Water:DISSOLVES
Appearance and Odor:OPAQUE WHITE GELATIN CAPSULES IN A 10ML FRENCH
SQUARE/GLASS/SCREW-CAP VIAL

Stability

Stability Indicator/Materials to Avoid:YES
Hazardous Decomposition Products:RADIOACTIVE FUMES, SODIUM IODIDE I
131.

Disposal

Waste Disposal Methods:STORAGE & DISPOSAL OF PRODUCT SHOULD BE
CONTROLLED IAW/FEDERAL, STATE & LOCAL REGULATIONS. UN2982.

Disclaimer (provided with this information by the compiling agencies):
This information is formulated for use by elements of the Department
of Defense. The United States of America in no manner whatsoever,
expressly or implied, warrants this information to be accurate and
disclaims all liability for its use. Any person utilizing this
document should seek competent professional advice to verify and
assume responsibility for the suitability of this information to their
particular situation.